Filing Details
- Accession Number:
- 0001213900-21-056737
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-04 16:00:37
- Reporting Period:
- 2021-11-03
- Accepted Time:
- 2021-11-04 16:00:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1711754 | Inmune Bio Inc. | INMB | Biological Products, (No Disgnostic Substances) (2836) | 475205835 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1767280 | Joseph Raymond Tesi | C/O Inmune Bio Inc. 225 Ne Mizner Blvd., Suite 640 Boca Raton, FL 33432 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-11-03 | 3,626 | $20.00 | 1,490,674 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.